A Randomized Active-controlled Study of AMG 162 in Breast Cancer Subjects With Bone Metastasis Who Have Not Previously Been Treated With Bisphosphonate Therapy.
A Randomized Active-controlled Study of AMG 162 in Breast Cancer Subjects With Bone Metastasis Who Have Not Previously Been Treated With Bisphosphonate Therapy.
This study is to evaluate various doses and schedules for denosumab administration and characterize the safety profile in this indication.
Inclusion Criteria: - Histologically or cytologically confirmed breast adenocarcinoma